A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
PHASE3
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2
This is a single-arm, multicenter, exploratory clinical study evaluating th...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
PHASE3
To compare the impact on recurrence risk of adjuvant TAI and adjuvant TACE ...